Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,394 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $586.70 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $156.54 | 10 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $104.62 | 6 | $0 (2023) |
| PFIZER INC. | $84.04 | 6 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $69.52 | 4 | $0 (2024) |
| VIVUS LLC | $68.66 | 4 | $0 (2022) |
| Celgene Corporation | $64.06 | 3 | $0 (2023) |
| Braintree Laboratories, Inc. | $46.95 | 2 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $38.61 | 2 | $0 (2018) |
| COLOPLAST CORP | $23.76 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.10 | 4 | Braintree Laboratories, Inc. ($26.32) |
| 2023 | $304.16 | 11 | AbbVie Inc. ($158.68) |
| 2022 | $419.61 | 17 | ABBVIE INC. ($197.49) |
| 2021 | $269.74 | 17 | AbbVie Inc. ($106.99) |
| 2020 | $138.49 | 9 | AbbVie Inc. ($80.55) |
| 2019 | $14.62 | 1 | Janssen Biotech, Inc. ($14.62) |
| 2018 | $149.83 | 10 | PFIZER INC. ($84.04) |
| 2017 | $11.15 | 1 | BOSTON SCIENTIFIC CORPORATION ($11.15) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | COLOPLAST CORP | Peristeen (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Continence Care | ||||||
| 08/28/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: GI COLON PREP | ||||||
| 04/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Immunology | ||||||
| 08/09/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Oncology | ||||||
| 05/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/09/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/13/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/23/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $101.89 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $31.34 | General |
| Category: Neuroscience | ||||||
| 12/13/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/29/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/12/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: GI COLON PREP | ||||||
| 08/10/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Neuroscience | ||||||
| 08/03/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Immunology | ||||||
| 06/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Gastroenterology | ||||||
| 06/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/31/2022 | Mallinckrodt Hospital Products Inc. | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 05/17/2022 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 512 | 542 | $380,974 | $55,745 |
| 2022 | 11 | 342 | 361 | $216,756 | $36,344 |
| 2021 | 11 | 582 | 619 | $184,759 | $64,522 |
| 2020 | 14 | 559 | 574 | $167,931 | $51,499 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 70 | 71 | $92,642 | $14,407 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 75 | 75 | $24,655 | $5,861 | 23.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 56 | $23,220 | $5,700 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 59 | $20,028 | $5,290 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 74 | 74 | $76,881 | $4,563 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 66 | $15,108 | $4,379 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $15,450 | $3,830 | 24.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $17,410 | $3,210 | 18.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $11,553 | $2,195 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 32 | $7,148 | $2,004 | 28.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $12,493 | $1,670 | 13.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $28,293 | $1,481 | 5.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $36,093 | $1,155 | 3.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 39 | $50,388 | $8,038 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $22,890 | $5,492 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 47 | $19,740 | $5,064 | 25.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 53 | $54,378 | $3,984 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 36 | $11,664 | $3,554 | 30.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $16,337 | $2,318 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,466 | $2,270 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 29 | $6,380 | $2,062 | 32.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $19,536 | $1,777 | 9.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 25 | $5,525 | $1,415 | 25.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 12 | $1,452 | $370.63 | 25.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 60 | 60 | $31,340 | $11,938 | 38.1% |
About Dr. Anil Singh, M.D
Dr. Anil Singh, M.D is a Gastroenterology healthcare provider based in Saint Cloud, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114975349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Singh, M.D has received a total of $1,394 in payments from pharmaceutical and medical device companies, with $86.10 received in 2024. These payments were reported across 70 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,394).
As a Medicare-enrolled provider, Singh has provided services to 1,995 Medicare beneficiaries, totaling 2,096 services with total Medicare billing of $208,110. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Saint Cloud, FL
- Active Since 05/04/2006
- Last Updated 12/20/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114975349
Products in Payments
- HUMIRA (Biological) $142.48
- STELARA (Biological) $136.74
- SKYRIZI (Biological) $101.89
- ENTYVIO (Biological) $87.63
- XIFAXAN (Drug) $69.52
- ZEPOSIA (Drug) $64.06
- XELJANZ (Drug) $61.37
- RINVOQ (Biological) $55.04
- LINZESS (Drug) $50.57
- SUTAB (Drug) $46.95
- MAVYRET (Drug) $40.65
- Trulance (Drug) $38.61
- PANCREAZE (Drug) $35.22
- Pancreaze (Drug) $33.44
- Humira (Biological) $27.18
- VIBERZI (Drug) $24.90
- Peristeen (Device) $23.76
- Cologuard Collection Kit (Device) $23.54
- INFLECTRA (Biological) $22.67
- REBYOTA (Biological) $22.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Saint Cloud
Bradley Currier, Md, MD
Gastroenterology — Payments: $469,764
Randy Saliares, Md, MD
Gastroenterology — Payments: $48.00
Scot Hutton, Md, MD
Gastroenterology — Payments: $14.50
Steven Bollinger, Md, MD
Gastroenterology — Payments: $14.50
Paul Dorsher, Md, MD
Gastroenterology
Peter Nelson, Md, MD
Gastroenterology